About Youngen

Youngen, based in Beijing, is a leading oligonucleotide therapeutic company built around  AOC modality. Youngen has been dedicated to develop RNAi therapeutics to a broad spectrum of difficult-to-treat diseases, both rare and general, impacting millions of people and families around the world. Leveraging cutting-edge technological platforms, we build globally competitive diversified product pipelines with first-in-classband Best-in-class potentials.We are advancing programs across key therapeutic areas, including cardiovascular, renal, central nervous system (CNS), and metabolic diseases, to deliver novel treatment options for patients in need.